IPI Terminal - Patent Intelligence Platform
IPI Terminal - Patent Intelligence Platform
DashboardSearchScreenerDaily ReportNewsInvestor IntelligenceMy Profile

Information

AboutTeamHow to UseIP GlossaryData SourcesContactSupport
Plans & Services
Sign InCreate Free Account
IPI Terminal - Patent Intelligence Platform
DashboardSearchScreenerDaily ReportNewsInvestor IntelligenceMy Profile

Information

AboutTeamHow to UseIP GlossaryData SourcesContactSupport
Plans & Services
Sign InCreate Free Account
Have a patent not listed?SUBMIT MY PATENT
AboutData SourcesContact|Terms of ServicePrivacy PolicyCookie PolicyCookie Settings

IPI Terminal is operated by Human IP SARL (Switzerland). Not legal, financial, or investment advice.

v1.5.38 · build irLZrdB · 2026-11-19 01:37 UTC

Full Legal Disclaimer

IPI Terminal is an intellectual property analytics and patent intelligence platform. Patent information, valuations, commercialization metrics, and analytical outputs are provided solely for informational and research purposes and do not constitute legal, financial, investment, tax, accounting, or other professional advice. Nothing on this platform constitutes an offer to sell, solicitation of an offer to buy, or recommendation regarding any security, digital asset, token, intellectual property interest, or financial instrument.

News & Analysis

Weekly patent market analysis, Patent of the Week features, and IP intelligence insights. Editorial coverage of innovation trends, patent value, and emerging technology sectors.

Patent of the Week

Our flagship weekly deep-dive on a patent with standout growth potential.

AllPatent of the WeekMarket InsightIndustry News
Patent of the WeekNov 20, 2026

Patent of the Week: Regeneron's Antibody-Based Treatment for Lower Back Pain

A novel NGF-targeting therapeutic method signaling strong potential in the pain management sector

Regeneron Pharmaceuticals has secured a key patent for a method treating lower back pain using an antibody targeting nerve growth factor. This innovation reflects significant technical novelty and market relevance in biologics for pain relief. Investors should monitor its development given Regeneron's established position and the sizable demand for effective non-opioid pain therapies.

IPI Terminal Editorial TeamRead
Patent of the WeekNov 5, 2026

Patent of the Week: Intelligent Recognition and Alert Methods and Systems Propel AI Object Detection

AI Concepts LLC secures a pivotal patent advancing neural network-based target object detection and real-time alerting.

AI Concepts LLC's patent US11537891B2 covers an AI-driven platform that intelligently detects target objects within content streams using learned profiles and neural networks. This innovation stands at the intersection of content analysis, security, and surveillance, showcasing robust technical sophistication and strong market relevance.

IPI Terminal Editorial TeamRead
Patent of the WeekOct 15, 2026

Patent of the Week: Targeted Replacement of Endogenous T Cell Receptors Advances Immunotherapy

University of California San Diego UCSD secures a key genome editing patent with promising applications in engineered T cell treatments

US11590171B2 introduces a sophisticated genome editing method for human T cells, enhancing the precision of T cell receptor replacement. Its strong citation record and high IP strength position it well within the expanding healthtech immunotherapy landscape.

IPI Terminal Editorial TeamRead
Patent of the WeekOct 9, 2026

Patent of the Week: Learning Observation Representations by Predicting the Future in Latent Space

DeepMind Technologies advances AI with a patent on future-focused latent representation learning

DeepMind Technologies' patent US11568207B2 presents a novel method for training encoder neural networks that predict future latent representations from sequences of observations. This addresses key challenges in AI and machine learning and positions DeepMind strategically within a competitive landscape driven by innovation in predictive modeling.

IPI Terminal Editorial TeamRead
Patent of the WeekOct 2, 2026

Patent of the Week: Small Molecule Passivation Boosts Quantum Dot Efficiency

Nanosys Inc advances quantum dot technology with improved surface chemistry for enhanced quantum yield

Nanosys Inc's patent US11549058B2 introduces a novel nanostructure composition employing metal halide and metal carboxylate surface passivation to improve quantum dot performance. This innovation targets applications in displays, lighting, and photovoltaics, reflecting strong commercial and licensing potential.

IPI Terminal Editorial TeamRead
Patent of the WeekSep 25, 2026

Patent of the Week: Battery Passivation Compensation Method for Medical Devices

Roche Diabetes Care Inc advances energy management in critical healthcare technology

Roche Diabetes Care Inc's patent US11532826B2 introduces a method to optimize battery performance in medical devices by addressing passivation effects. This innovation targets reliability and efficiency improvements essential for the growing medical device market. Its strong patent metrics and strategic relevance underscore its commercial significance.

IPI Terminal Editorial TeamRead
Patent of the WeekSep 18, 2026

Patent of the Week: Multi-ligand Drug Conjugates for Targeted Therapeutics

Coherent Biopharma’s US11571480B2 advances precision drug delivery through multi-ligand conjugate technology

Coherent Biopharma Ltd’s patent US11571480B2 introduces innovative multi-ligand drug conjugates that enhance targeted payload delivery to cell surface receptors. This technology holds promise for improving therapeutic outcomes in complex disease treatment. The patent’s strong citation record and HIS score reflect its high impact within the biotech sector.

IPI Terminal Editorial TeamRead
Patent of the WeekSep 11, 2026

Patent of the Week: Stabilized Copper Selenide Thermoelectric Materials Advance Energy Conversion

University of Michigan System patents nanocomposite technology for enhanced thermoelectric performance

This week’s featured patent covers a novel thermoelectric nanocomposite material developed by the University of Michigan System. The invention promises high figure of merit values through a stabilized copper selenide matrix, positioning it well for applications in energy efficiency and waste heat recovery.

IPI Terminal Editorial TeamRead
Patent of the WeekSep 4, 2026

Patent of the Week: IBM Advances ReRAM with Novel Resistive Switching Memory Cell

International Business Machines Corp strengthens its position in next-generation memory technologies with a sophisticated resistive switching device

US11502252B2 presents a weighted advancement in resistive random access memory (ReRAM) technology featuring a high work function metal core for enhanced performance at the nanoscale. This invention by IBM holds significant promise in the evolving landscape of high-density memory and neuromorphic computing applications.

IPI Terminal Editorial TeamRead
Patent of the WeekAug 28, 2026

Patent of the Week: Compositions Targeting Tumor-Associated Macrophages for Cancer and Inflammatory Diseases

Advanced peptide compositions offer novel approaches in diagnosing and treating tumor-associated macrophages within complex disease contexts.

Sanford Burnham Prebys Medical Discovery Institute's patent US11571484B2 demonstrates innovation in bioengineering peptides that target tumor-associated macrophages. This technology spans both diagnostic and therapeutic applications in cancer and inflammatory disorders, signaling strategic importance within the healthtech domain despite development and market challenges.

IPI Terminal Editorial TeamRead
PrevPage 1 of 2Next